203 related articles for article (PubMed ID: 37450072)
1. Belzutifan in adults with VHL-associated central nervous system hemangioblastoma: a single-center experience.
Neth BJ; Webb MJ; White J; Uhm JH; Pichurin PN; Sener U
J Neurooncol; 2023 Aug; 164(1):239-247. PubMed ID: 37450072
[TBL] [Abstract][Full Text] [Related]
2. The outcome of central nervous system hemangioblastomas in Von Hippel-Lindau (VHL) disease treated with belzutifan: a single-institution retrospective experience.
Zamarud A; Marianayagam NJ; Park DJ; Yener U; Yoo KH; Meola A; Chang SD
J Neurooncol; 2023 Nov; 165(2):373-379. PubMed ID: 37955759
[TBL] [Abstract][Full Text] [Related]
3. FDA Approval Summary: Belzutifan for von Hippel-Lindau Disease-Associated Tumors.
Fallah J; Brave MH; Weinstock C; Mehta GU; Bradford D; Gittleman H; Bloomquist EW; Charlab R; Hamed SS; Miller CP; Dorff SE; Chambers WA; Mixter BD; Dinin J; Pierce WF; Ricks TK; Tang S; Donoghue M; Pazdur R; Amiri-Kordestani L; Ibrahim A; Beaver JA
Clin Cancer Res; 2022 Nov; 28(22):4843-4848. PubMed ID: 35727604
[TBL] [Abstract][Full Text] [Related]
4. Neurological applications of belzutifan in von Hippel-Lindau disease.
Zhang Y; Nguyen CC; Zhang NT; Fink NS; John JD; Venkatesh OG; Roe JD; Hoffman SC; Lesniak MS; Wolinsky JP; Horbinski C; Szymaniak BM; Buerki RA; Sosman JA; Shenoy NK; Lukas RV
Neuro Oncol; 2023 May; 25(5):827-838. PubMed ID: 36215167
[TBL] [Abstract][Full Text] [Related]
5. First clinical experience with belzutifan in von Hippel-Lindau disease associated CNS hemangioblastoma.
Dhawan A; Peereboom DM; Stevens GH
CNS Oncol; 2022 Jul; 11(3):CNS91. PubMed ID: 35819008
[TBL] [Abstract][Full Text] [Related]
6. Exceptional and Sustained Response to Belzutifan in Von Hippel-Lindau Disease-Associated Central Nervous System Hemangioblastoma.
Thalji M; Vadlapatla V; Avgeropoulos NG; Ramakrishna N; Baidas S
Cureus; 2024 Jan; 16(1):e52979. PubMed ID: 38406059
[TBL] [Abstract][Full Text] [Related]
7. Belzutifan for Renal Cell Carcinoma in von Hippel-Lindau Disease.
Jonasch E; Donskov F; Iliopoulos O; Rathmell WK; Narayan VK; Maughan BL; Oudard S; Else T; Maranchie JK; Welsh SJ; Thamake S; Park EK; Perini RF; Linehan WM; Srinivasan R;
N Engl J Med; 2021 Nov; 385(22):2036-2046. PubMed ID: 34818478
[TBL] [Abstract][Full Text] [Related]
8. Management of von Hippel-Lindau disease-associated CNS lesions.
Wind JJ; Lonser RR
Expert Rev Neurother; 2011 Oct; 11(10):1433-41. PubMed ID: 21955200
[TBL] [Abstract][Full Text] [Related]
9. Belzutifan in a Patient With VHL-Associated Metastatic Pancreatic Neuroendocrine Tumor.
Pelle E; Al-Toubah T; Morse B; Strosberg J
J Natl Compr Canc Netw; 2022 Dec; 20(12):1285-1287. PubMed ID: 36509068
[TBL] [Abstract][Full Text] [Related]
10. Genotype-phenotype analysis of von Hippel-Lindau syndrome in Korean families: HIF-α binding site missense mutations elevate age-specific risk for CNS hemangioblastoma.
Lee JS; Lee JH; Lee KE; Kim JH; Hong JM; Ra EK; Seo SH; Lee SJ; Kim MJ; Park SS; Seong MW
BMC Med Genet; 2016 Jul; 17(1):48. PubMed ID: 27439424
[TBL] [Abstract][Full Text] [Related]
11. Belzutifan for von Hippel-Lindau Disease: Pancreatic Lesion Population of the Phase 2 LITESPARK-004 Study.
Else T; Jonasch E; Iliopoulos O; Beckermann KE; Narayan V; Maughan BL; Oudard S; Maranchie JK; Iversen AB; Goldberg CM; Fu W; Perini RF; Liu Y; Linehan WM; Srinivasan R
Clin Cancer Res; 2024 May; 30(9):1750-1757. PubMed ID: 38393723
[TBL] [Abstract][Full Text] [Related]
12. Intronic mutation of the VHL gene associated with central nervous system hemangioblastomas in two Chinese families with Von Hippel-Lindau disease: case report.
Liu Z; Zhou J; Li L; Yi Z; Lu R; Li C; Gong K
BMC Med Genet; 2020 Oct; 21(1):191. PubMed ID: 33004005
[TBL] [Abstract][Full Text] [Related]
13. Propranolol reduces viability and induces apoptosis in hemangioblastoma cells from von Hippel-Lindau patients.
Albiñana V; Villar Gómez de Las Heras K; Serrano-Heras G; Segura T; Perona-Moratalla AB; Mota-Pérez M; de Campos JM; Botella LM
Orphanet J Rare Dis; 2015 Sep; 10():118. PubMed ID: 26394686
[TBL] [Abstract][Full Text] [Related]
14. Prospective natural history study of central nervous system hemangioblastomas in von Hippel-Lindau disease.
Lonser RR; Butman JA; Huntoon K; Asthagiri AR; Wu T; Bakhtian KD; Chew EY; Zhuang Z; Linehan WM; Oldfield EH
J Neurosurg; 2014 May; 120(5):1055-62. PubMed ID: 24579662
[TBL] [Abstract][Full Text] [Related]
15. Sporadic and Von-Hippel Lindau disease-associated spinal hemangioblastomas: institutional experience on their similarities and differences.
Yousef A; Rutkowski MJ; Yalcin CE; Eren OC; Caliskan I; Tihan T
J Neurooncol; 2019 Jul; 143(3):547-552. PubMed ID: 31089924
[TBL] [Abstract][Full Text] [Related]
16. Metastases to hemangioblastomas in von Hippel-Lindau disease.
Jarrell ST; Vortmeyer AO; Linehan WM; Oldfield EH; Lonser RR
J Neurosurg; 2006 Aug; 105(2):256-63. PubMed ID: 17219831
[TBL] [Abstract][Full Text] [Related]
17. Role of VHL-JAK-STAT signaling pathway in central nervous system hemangioblastoma associated with von Hippel-Lindau disease.
Kanno H; Yoshizumi T; Shinonaga M; Kubo A; Murata H; Yao M
J Neurooncol; 2020 May; 148(1):29-38. PubMed ID: 32356150
[TBL] [Abstract][Full Text] [Related]
18. Extraneuraxial hemangioblastoma: A clinicopathologic study of 10 cases with molecular analysis of the VHL gene.
Muscarella LA; Bisceglia M; Galliani CA; Zidar N; Ben-Dor DJ; Pasquinelli G; la Torre A; Sparaneo A; Fanburg-Smith JC; Lamovec J; Michal M; Bacchi CE
Pathol Res Pract; 2018 Aug; 214(8):1156-1165. PubMed ID: 29941223
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology and economic burden of Von Hippel-Lindau Disease-associated central nervous system hemangioblastomas and pancreatic neuroendocrine tumors in the United States.
Jonasch E; Song Y; Freimark J; Berman R; Nguyen H; Signorovitch J; Sundaram M
Orphanet J Rare Dis; 2024 Feb; 19(1):73. PubMed ID: 38365728
[TBL] [Abstract][Full Text] [Related]
20. Developmental effects of von Hippel-Lindau gene deficiency.
Vortmeyer AO; Yuan Q; Lee YS; Zhuang Z; Oldfield EH
Ann Neurol; 2004 May; 55(5):721-8. PubMed ID: 15122713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
